Moreover, in the high Ki-67 group, the percentage of peritumoral edema, CSF space surrounding tumor, absent capsular enhancement, heterogeneous enhancement, and intratumoral necrosis was 78.5%, 58.1%, 25.0%, 59.3%, and 30.8%, respectively, while the percentages in the low Ki-67 group were 70.4%, 49.2%, 17.1%, 48.2%, and 22.6%, respectively. The gene discussed is MKI67; the disease is neoplasm.